Ricardo Bellott

427 total citations
13 papers, 329 citations indexed

About

Ricardo Bellott is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ricardo Bellott has authored 13 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Ricardo Bellott's work include Pharmacogenetics and Drug Metabolism (4 papers), Cancer therapeutics and mechanisms (2 papers) and Blood properties and coagulation (2 papers). Ricardo Bellott is often cited by papers focused on Pharmacogenetics and Drug Metabolism (4 papers), Cancer therapeutics and mechanisms (2 papers) and Blood properties and coagulation (2 papers). Ricardo Bellott collaborates with scholars based in France, United Kingdom and Belgium. Ricardo Bellott's co-authors include Jacques Robert, Valérie Le Morvan, Virginie Charasson, Simone Mathoulin‐Pélissier, Michel Longy, Delphine Meynard, Philippe Gorry, Jacques Bonnet, Denis Smith and David A. Gewirtz and has published in prestigious journals such as Cancer Research, British Journal of Cancer and Human Reproduction.

In The Last Decade

Ricardo Bellott

13 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ricardo Bellott France 9 160 123 51 50 35 13 329
Linda D. Compton United States 5 224 1.4× 260 2.1× 30 0.6× 39 0.8× 30 0.9× 12 490
S P Khor United States 9 105 0.7× 254 2.1× 35 0.7× 22 0.4× 29 0.8× 10 422
Roger Y. Tsang Canada 8 135 0.8× 154 1.3× 15 0.3× 21 0.4× 34 1.0× 21 399
Michael Burgess United Kingdom 8 219 1.4× 322 2.6× 48 0.9× 40 0.8× 18 0.5× 15 486
Sikic Bi United States 10 276 1.7× 282 2.3× 25 0.5× 18 0.4× 24 0.7× 13 547
Agneta Freijs Sweden 8 85 0.5× 249 2.0× 67 1.3× 16 0.3× 41 1.2× 9 368
Madhu B. Garg Australia 11 130 0.8× 243 2.0× 36 0.7× 19 0.4× 34 1.0× 17 394
Raymond S. Lord United States 6 184 1.1× 182 1.5× 24 0.5× 38 0.8× 17 0.5× 7 337
Peter Nygren Sweden 11 141 0.9× 184 1.5× 20 0.4× 25 0.5× 31 0.9× 14 401
Miguel A. Villalona United States 5 191 1.2× 191 1.6× 23 0.5× 17 0.3× 23 0.7× 8 344

Countries citing papers authored by Ricardo Bellott

Since Specialization
Citations

This map shows the geographic impact of Ricardo Bellott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Bellott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Bellott more than expected).

Fields of papers citing papers by Ricardo Bellott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Bellott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Bellott. The network helps show where Ricardo Bellott may publish in the future.

Co-authorship network of co-authors of Ricardo Bellott

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Bellott. A scholar is included among the top collaborators of Ricardo Bellott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Bellott. Ricardo Bellott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Morvan, Valérie Le, Saskia Litière, Audrey Laroche‐Clary, et al.. (2014). Identification of SNPs associated with response of breast cancer patients to neoadjuvant chemotherapy in the EORTC-10994 randomized phase III trial. The Pharmacogenomics Journal. 15(1). 63–68. 14 indexed citations
2.
Morvan, Valérie Le, et al.. (2012). Abstract 1871: Role of CYP1B1 gene polymorphisms in anticancer drug cytotoxicity as studied on isogenic cell lines. Cancer Research. 72(8_Supplement). 1871–1871. 2 indexed citations
3.
Di, Xu, Ricardo Bellott, Jacques Robert, et al.. (2008). A chemotherapy-associated senescence bystander effect in breast cancer cells. Cancer Biology & Therapy. 7(6). 864–872. 44 indexed citations
4.
Bellott, Ricardo, Valérie Le Morvan, Virginie Charasson, et al.. (2007). Functional study of the 830C>G polymorphism of the human carboxylesterase 2 gene. Cancer Chemotherapy and Pharmacology. 61(3). 481–488. 19 indexed citations
5.
Morvan, Valérie Le, Denis Smith, Véronique Brouste, et al.. (2007). Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val Gene Polymorphisms In Colorectal Cancer Patients: Relationships with Treatment Outcome. Pharmacogenomics. 8(12). 1693–1703. 40 indexed citations
6.
Bellott, Ricardo, et al.. (2006). Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI60 panel. Cancer Research. 66. 311–311. 2 indexed citations
7.
Lowis, Stephen P., Ian Lewis, Claire Weston, et al.. (2006). A phase I study of intravenous liposomal daunorubicin (DaunoXome) in paediatric patients with relapsed or resistant solid tumours. British Journal of Cancer. 95(5). 571–580. 38 indexed citations
8.
Morvan, Valérie Le, et al.. (2006). Relationships Between Genetic Polymorphisms and Anticancer Drug Cytotoxicity Vis-à-Vis the NCI-60 Panel. Pharmacogenomics. 7(6). 843–852. 26 indexed citations
9.
Charasson, Virginie, Ricardo Bellott, Delphine Meynard, et al.. (2004). Pharmacogenetics of human carboxylesterase 2, an enzyme involved in the activation of irinotecan into SN-38. Clinical Pharmacology & Therapeutics. 76(6). 528–535. 56 indexed citations
10.
Bellott, Ricardo, et al.. (2001). Separation and determination of liposomal and non-liposomal daunorubicin from the plasma of patients treated with Daunoxome. Journal of Chromatography B Biomedical Sciences and Applications. 757(2). 257–267. 32 indexed citations
11.
Bellott, Ricardo, Anne Auvrignon, Thierry Leblanc, et al.. (2000). Pharmacokinetics of liposomal daunorubicin (DaunoXome) during a phase I-II study in children with relapsed acute lymphoblastic leukaemia. Cancer Chemotherapy and Pharmacology. 47(1). 15–21. 52 indexed citations
12.
Bellott, Ricardo, et al.. (1991). Evidence for an alpha 2-macroglobulin with complement-inhibiting activity in rat serum.. PubMed. 72(2). 151–61. 2 indexed citations
13.
Lestage, Jacques, et al.. (1990). Characterization of one α2-macroglobulin with anticomplementary activity from pregnant women. Human Reproduction. 5(6). 747–754. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda D. Compton Breakdown of academic impact, for papers by S P Khor Breakdown of academic impact, for papers by Roger Y. Tsang Breakdown of academic impact, for papers by Michael Burgess Breakdown of academic impact, for papers by Sikic Bi Breakdown of academic impact, for papers by Agneta Freijs Breakdown of academic impact, for papers by Madhu B. Garg Breakdown of academic impact, for papers by Raymond S. Lord Breakdown of academic impact, for papers by Peter Nygren Breakdown of academic impact, for papers by Miguel A. Villalona
Rankless by CCL
2026